Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
M2D2 Support and Seed Funding Available for Medical-Device Entrepreneurs Biodetection November 30, 2018 …
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments Medical Countermeasures May 18, 2018 …
